Quantum Computing (QUBT) had the highest return between July 1, 2017 and September 30, 2018 by a mid-cap US stock, returning 5,650%.
| ASSET | DATE | % RETURN |
|---|---|---|
Quantum Computing (QUBT) | 7/1/2017 - 9/30/2018 | 5,650% |
Viking Therapeutics (VKTX) | 7/1/2017 - 9/30/2018 | 1,512.96% |
Madrigal Pharmaceuticals (MDGL) | 7/1/2017 - 9/30/2018 | 1,219.35% |
Arrowhead Pharmaceuticals (ARWR) | 7/1/2017 - 9/30/2018 | 1,068.9% |
Tilray (TLRY) | 7/1/2017 - 9/30/2018 | 523.08% |
Uniqure (QURE) | 7/1/2017 - 9/30/2018 | 478.54% |
Enphase Energy (ENPH) | 7/1/2017 - 9/30/2018 | 457.47% |
Skyline (SKY) | 7/1/2017 - 9/30/2018 | 396.3% |
Sarepta Therapeutics (SRPT) | 7/1/2017 - 9/30/2018 | 377.7% |
Xenon Pharmaceuticals (XENE) | 7/1/2017 - 9/30/2018 | 315.62% |
Boot Barn (BOOT) | 7/1/2017 - 9/30/2018 | 298.46% |
GDS (GDS) | 7/1/2017 - 9/30/2018 | 280.19% |
Etsy (ETSY) | 7/1/2017 - 9/30/2018 | 242.53% |
Match (MTCH) | 7/1/2017 - 9/30/2018 | 231.86% |
Warrior Met Coal (HCC) | 7/1/2017 - 9/30/2018 | 224.45% |
Haemonetics (HAE) | 7/1/2017 - 9/30/2018 | 187.82% |
Northern Oil & Gas (NOG) | 7/1/2017 - 9/30/2018 | 185.71% |
Goosehead Insurance (GSHD) | 7/1/2017 - 9/30/2018 | 182.25% |
Chefs Warehouse (CHEF) | 7/1/2017 - 9/30/2018 | 179.62% |
Crispr Therapeutics (CRSP) | 7/1/2017 - 9/30/2018 | 177.71% |
Crocs (CROX) | 7/1/2017 - 9/30/2018 | 175.78% |
HF Sinclair (DINO) | 7/1/2017 - 9/30/2018 | 162.41% |
Five Below (FIVE) | 7/1/2017 - 9/30/2018 | 161.69% |
Align Technology (ALGN) | 7/1/2017 - 9/30/2018 | 158.98% |
Vicor (VICR) | 7/1/2017 - 9/30/2018 | 156.27% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
